Luisa Camoglio

930 total citations
13 papers, 772 citations indexed

About

Luisa Camoglio is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Luisa Camoglio has authored 13 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Luisa Camoglio's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (4 papers) and Immune Response and Inflammation (4 papers). Luisa Camoglio is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (4 papers) and Immune Response and Inflammation (4 papers). Luisa Camoglio collaborates with scholars based in Netherlands, Slovakia and Switzerland. Luisa Camoglio's co-authors include Sander J. H. van Deventer, Tom van der Poll, Nicole P. Juffermans, Anje A. te Velde, Pranab K. Das, A. J. Tigges, Sandrine Florquin, Annelies Verbon, S J van Deventer and Peter Speelman and has published in prestigious journals such as The Journal of Immunology, The Journal of Infectious Diseases and European Journal of Immunology.

In The Last Decade

Luisa Camoglio

13 papers receiving 755 citations

Peers

Countries citing papers authored by Luisa Camoglio

Since Specialization

Citations

This map shows the geographic impact of Luisa Camoglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Camoglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Camoglio more than expected).

Fields of papers citing papers by Luisa Camoglio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Camoglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Camoglio. The network helps show where Luisa Camoglio may publish in the future.

Co-authorship network of co-authors of Luisa Camoglio

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Camoglio. A scholar is included among the top collaborators of Luisa Camoglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Camoglio. Luisa Camoglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis 2002 ·Pure Amsterdam UMC ·Luisa Camoglio, (unknown), Maikel P. Peppelenbosch, (unknown), (unknown), (unknown), Manfred Köpf	1
2	Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis 2002 ·European Journal of Immunology ·Luisa Camoglio, Nicole P. Juffermans, Maikel P. Peppelenbosch, Anje A. te Velde, Fibo J. ten Kate, Sander J. H. van Deventer, Manfred Köpf	68
3	Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-γ receptor-deficient mice 2000 ·European Journal of Immunology ·Luisa Camoglio, Anje A. te Velde, Angela G. E. M. de Boer, Fibo J. ten Kate, Manfred Köpf, S J van Deventer	71
4	Interleukin‐1 Signaling Is Essential for Host Defense during Murine Pulmonary Tuberculosis 2000 ·The Journal of Infectious Diseases ·Nicole P. Juffermans, Sandrine Florquin, Luisa Camoglio, Annelies Verbon, A H Kolk, Peter Speelman, Sander J. H. van Deventer, Tom van der Poll	227
5	Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis? 1999 ·European Journal of Gastroenterology & Hepatology ·Aurélien Marc, Hilde Kuiper, Luisa Camoglio, (unknown), E. Anthony Jones, Guido N.J. Tytgat, Sander J. H. van Deventer	17
6	IFN-γ receptor deficient mice are not proteclied against TNBS induced colitis 1999 ·European Journal of Gastroenterology & Hepatology ·Luisa Camoglio, Anje A. te Velde, Angela G. E. M. de Boer, (unknown), F.J.W. ten Kate, Manfred Köpf, (unknown)	2
7	Altered expression of interferon-γ and interleukin-4 in inflammatory bowel disease 1998 ·Inflammatory Bowel Diseases ·Luisa Camoglio, Anje A. te Velde, A. J. Tigges, Pranab K. Das, Sander J. H. van Deventer	105
8	Altered Expression of Interferon-γ and Interleukin-4 in Inflammatory Bowel Disease 1998 ·Inflammatory Bowel Diseases ·Luisa Camoglio, Anje A. te Velde, A. J. Tigges, Pranab K. Das, Sander J. H. van Deventer	67
9	Immunotherapy of Crohn′s disease 1998 ·Mediators of Inflammation ·Catherine van Montfrans, Luisa Camoglio, Sander J. H. van Deventer	11
10	Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy. 1997 ·PubMed ·(unknown), Luisa Camoglio, (unknown)	31
11	Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration 1997 ·The Journal of Immunology ·Dasja Pajkrt, Luisa Camoglio, (unknown), K. de Bruin, David L. Cutler, M B Affrime, Gijs Rikken, Tom van der Poll, J W ten Cate, S J van Deventer	159
12	Monoclonal antibody therapy of inflammatory bowel disease. 1997 ·Pharmacy World & Science ·Sander J. H. van Deventer, Luisa Camoglio	7
13	Monoclonal antibody therapy of inflammatory bowel disease. 1996 ·PubMed ·SJ van Deventer, Luisa Camoglio	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact